Clearstead Trust’s Pediatrix Medical MD Stock Holding History

Clearstead Trust’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-34	Closed	-$570	–	1317
2025 Q3	$570	Hold	34	–	–	﹤0.01%	1349
2025 Q2	$488	Buy	+34	New	+$466	﹤0.01%	1334

Other funds holding MD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Clearstead Trust's MD Position: Q4 2025 in Review

Clearstead Trust sold out of Pediatrix Medical (MD) in Q4 2025, closing a stake of 34 shares — an estimated $570 sold.

Clearstead Trust first reported a position in MD in Q2 2025 and held it in 2 quarters. The position peaked at $570 in Q3 2025. 299 funds tracked by Wall St. Rank hold MD as of Q4 2025.

Clearstead Trust reported no remaining Pediatrix Medical position as of Q4 2025 after selling out during the quarter.
Clearstead Trust sold 34 Pediatrix Medical shares in Q4 2025, an estimated $570.
Clearstead Trust first reported a position in Pediatrix Medical in Q2 2025 and held it in 2 quarters.
Clearstead Trust's Pediatrix Medical position peaked at $570 in Q3 2025.
299 funds tracked by Wall St. Rank held Pediatrix Medical as of Q4 2025.

Based on Clearstead Trust's 13F filing for Q4 2025, filed 9 Feb 2026.